This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Wilson, N. A.
Right arrow Articles by Watkins, D. I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, N. A.
Right arrow Articles by Watkins, D. I.

 Previous Article  |  Next Article 

Journal of Virology, July 2009, p. 6508-6521, Vol. 83, No. 13
0022-538X/09/$08.00+0     doi:10.1128/JVI.00272-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge{triangledown} ,{dagger}

Nancy A. Wilson,1* Brandon F. Keele,3 Jason S. Reed,1 Shari M. Piaskowski,1 Caitlin E. MacNair,1 Andrew J. Bett,5 Xiaoping Liang,5 Fubao Wang,5 Elizabeth Thoryk,5 Gwendolyn J. Heidecker,5 Michael P. Citron,5 Lingyi Huang,5 Jing Lin,5 Salvatore Vitelli,5 Chanook D. Ahn,1 Masahiko Kaizu,1 Nicholas J. Maness,1 Matthew R. Reynolds,1 Thomas C. Friedrich,1,2 John T. Loffredo,1 Eva G. Rakasz,1 Stephen Erickson,4 David B. Allison,4 Michael Piatak Jr.,6 Jeffrey D. Lifson,6 John W. Shiver,5 Danilo R. Casimiro,5 George M. Shaw,3 Beatrice H. Hahn,3 and David I. Watkins1

Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin,1 Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin,2 Departments of Medicine and Microbiology, University of Alabama at Birmingham, Birmingham, Alabama,3 Section on Statistical Genetics, Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama,4 Merck Research Labs, West Point, Pennsylvania,5 SAIC Frederick, Inc., NCI-Frederick, Frederick, Maryland6

Received 6 February 2009/ Accepted 22 April 2009

All human immunodeficiency virus (HIV) vaccine efficacy trials to date have ended in failure. Structural features of the Env glycoprotein and its enormous variability have frustrated efforts to induce broadly reactive neutralizing antibodies. To explore the extent to which vaccine-induced cellular immune responses, in the absence of neutralizing antibodies, can control replication of a heterologous, mucosal viral challenge, we vaccinated eight macaques with a DNA/Ad5 regimen expressing all of the proteins of SIVmac239 except Env. Vaccinees mounted high-frequency T-cell responses against 11 to 34 epitopes. We challenged the vaccinees and eight naïve animals with the heterologous biological isolate SIVsmE660, using a regimen intended to mimic typical HIV exposures resulting in infection. Viral loads in the vaccinees were significantly less at both the peak (1.9-log reduction; P < 0.03) and at the set point (2.6-log reduction; P < 0.006) than those in control naïve animals. Five of eight vaccinated macaques controlled acute peak viral replication to less than 80,000 viral RNA (vRNA) copy eq/ml and to less than 100 vRNA copy eq/ml in the chronic phase. Our results demonstrate that broad vaccine-induced cellular immune responses can effectively control replication of a pathogenic, heterologous AIDS virus, suggesting that T-cell-based vaccines may have greater potential than previously appreciated.


* Corresponding author. Mailing address: University of Wisconsin, AIDS Vaccine Development Laboratory, 555 Science Drive, Madison, WI 53711. Phone: (608) 445-0459. Fax: (608) 265-8084. E-mail: nwilson{at}primate.wisc.edu

{triangledown} Published ahead of print on 29 April 2009.

{dagger} Supplemental material for this article may be found at http://jvi.asm.org/.


Journal of Virology, July 2009, p. 6508-6521, Vol. 83, No. 13
0022-538X/09/$08.00+0     doi:10.1128/JVI.00272-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Beignon, A.-S., Mollier, K., Liard, C., Coutant, F., Munier, S., Riviere, J., Souque, P., Charneau, P. (2009). Lentiviral Vector-Based Prime/Boost Vaccination against AIDS: Pilot Study Shows Protection against Simian Immunodeficiency Virus SIVmac251 Challenge in Macaques. J. Virol. 83: 10963-10974 [Abstract] [Full Text]